Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
Amanj Kurdi, Nouf Abutheraa, Lina Akil, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 22

Showing 22 citing articles:

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
Abdullahi Rabiu Abubakar, Ibrahim Sani, Brian Godman, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 4673-4695
Open Access | Times Cited: 61
Evidence-based public policy making for medicines across countries: findings and implications for the future
Brian Godman, Joseph Fadare, Hye-Young Kwon, et al.
Journal of Comparative Effectiveness Research (2021) Vol. 10, Iss. 12, pp. 1019-1052
Open Access | Times Cited: 35
Current systematic reviews and meta-analyses of COVID-19
Mahmoud Nassar, Nso Nso, Mostafa Alfishawy, et al.
World Journal of Virology (2021) Vol. 10, Iss. 4, pp. 182-208
Open Access | Times Cited: 27
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
Pathomechanisms and Treatment Implications for Stroke in COVID-19: A Review of the Literature
Brian Stamm, Deborah Huang, Regina Royan, et al.
Life (2022) Vol. 12, Iss. 2, pp. 207-207
Open Access | Times Cited: 17
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
Amanj Kurdi, Tanja Mueller, Natalie Weir
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 2
Open Access | Times Cited: 12
Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, et al.
Revista Portuguesa de Cardiologia (2023) Vol. 42, Iss. 4, pp. 373-383
Open Access | Times Cited: 7
Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis
Na Jia, Guifang Zhang, Xuelin Sun, et al.
Journal of Clinical Hypertension (2021) Vol. 23, Iss. 9, pp. 1651-1663
Open Access | Times Cited: 15
Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank
Holly Pavey, Spoorthy Kulkarni, Angela Wood, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0276781-e0276781
Open Access | Times Cited: 9
Assembly of In-Situ Gel Containing Nano-Spanlastics of an Angiotensin II Inhibitor as a Novel Epitome for Hypertension Management: Factorial Design Optimization, In-vitro Gauging, Pharmacokinetics, and Pharmacodynamics Appraisal
Heba F. Salem, Mohamed M. Nafady, Dalia Essam Eissa, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Katherine Mackey, Devan Kansagara, Kathryn Vela
Annals of Internal Medicine (2021) Vol. 174, Iss. 2, pp. W25-W29
Open Access | Times Cited: 9
Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study
Molly M. Jeffery, Lucas Oliveira J. e Silva, Fernanda Bellolio, et al.
BMJ Open (2022) Vol. 12, Iss. 7, pp. e060305-e060305
Open Access | Times Cited: 6
Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis
Laura Soldevila, Lluís Valerio-Sallent, Sílvia Roure, et al.
International Journal of Infectious Diseases (2021) Vol. 109, pp. 192-194
Open Access | Times Cited: 7
Overview of the cardio-metabolic impact of the COVID-19 pandemic
Maryam Barkhordarian, Arezoo Behbood, Maryam Ranjbar, et al.
Endocrine (2023) Vol. 80, Iss. 3, pp. 477-490
Open Access | Times Cited: 2
Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Katherine Mackey, Devan Kansagara, Kathryn Vela
Annals of Internal Medicine (2020) Vol. 174, Iss. 1, pp. W17-W17
Open Access | Times Cited: 2
Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
Junxiong Ma, Shuduo Zhou, Na Li, et al.
BMJ Open (2022) Vol. 12, Iss. 11, pp. e059720-e059720
Open Access | Times Cited: 1
An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
Amanj Kurdi, Natalie Weir, Tanja Mueller
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Arterial Hypertension and Risk of Mortality in Patients with COVID-19 Infection
Nikolina Bukal, I. Golubic, Bojan Jelaković, et al.
Southeastern European medical journal (2022) Vol. 6, Iss. 1, pp. 74-82
Open Access
Comparative study of the use of antihypertensives and their relationship with sars-cov-2
Franklin Francisco Castro Mindiola, Pilar Asunción Soledispa Cañarte
Deleted Journal (2022) Vol. 1, pp. 96-96
Closed Access
A Shot in the Dark! RAAS Inhibitors Cause Severe COVID-19 Infection
Bhuvana Krishna
Indian Journal of Critical Care Medicine (2021) Vol. 25, Iss. 4, pp. 353-354
Open Access
The effect of renin-angiotensin-aldosterone blockers on SARS-CoV-2 infection in adults: a systematic review of studies and meta-analyzes
М. В. Леонова
Meditsinskiy sovet = Medical Council (2021), Iss. 4, pp. 26-33
Open Access
Page 1

Scroll to top